EI
251.2
-0.83%↓
SAN
81.4
+0.28%↑
SHL.DE
45.79
-0.93%↓
ARGX
548.8
-1.72%↓
PHIA
23.14
+0.74%↑
EI
251.2
-0.83%↓
SAN
81.4
+0.28%↑
SHL.DE
45.79
-0.93%↓
ARGX
548.8
-1.72%↓
PHIA
23.14
+0.74%↑
EI
251.2
-0.83%↓
SAN
81.4
+0.28%↑
SHL.DE
45.79
-0.93%↓
ARGX
548.8
-1.72%↓
PHIA
23.14
+0.74%↑
EI
251.2
-0.83%↓
SAN
81.4
+0.28%↑
SHL.DE
45.79
-0.93%↓
ARGX
548.8
-1.72%↓
PHIA
23.14
+0.74%↑
EI
251.2
-0.83%↓
SAN
81.4
+0.28%↑
SHL.DE
45.79
-0.93%↓
ARGX
548.8
-1.72%↓
PHIA
23.14
+0.74%↑
24h
Current
Min
108
Max
109.85
Income | 68M 735M |
---|---|
Sales | -138M 5.3B |
P/E Sector Avg | 26.27 34.393 |
EPS | 2.07 |
Dividend yield | 1.34 |
Profit margin | 13.92 |
EBITDA | 1.6B |
Recommendations | Buy |
---|---|
12 Months Forecast | +35.06% upside |
Dividend yield Sector Avg | 1.34% 2.54% |
---|
Market Cap | 38B 98B |
---|---|
Previous open | 108.61 |
Previous close | 109.9 |
By Acuity
19%
81%
28 / 374 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
121.15 / 123.55 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
7 sie 2025, 05:43 UTC
Germany's Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales
DJ
Read
15 maj 2025, 08:36 UTC
Merck KGaA Shares Plunge After Outlook Cut on Tariff, Currency Risks
DJ
Read
15 maj 2025, 05:25 UTC
Merck KGaA Cuts Outlook Amid Macroeconomic Challenges
DJ
Read
7 sie 2025, 08:04 UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Group Ebitda Before Exceptional Items of EUR5.8B-EUR6.4B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Had Guided for 2025 Group Sales of EUR20.9B-EUR22.4B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Organic Growth in Ebitda Before Exceptional Items at 2%-7%
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth at 2%-6%
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Now Sees 2025 Group Ebitda Before Exceptional Items of EUR5.9B-EUR6.3B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Now Sees 2025 Organic Growth in Ebitda Before Exceptional Items at 4%-8%
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Cuts 2025 View To Sales EUR20.5B-EUR21.7B
DJ
Read
7 sie 2025, 05:00 UTC
Analysts Saw Merck KGaA 2Q Sales at EUR5.32B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Organic Sales Growth at 2%-5%
DJ
Read
7 sie 2025, 05:00 UTC
Analysts Saw Merck KGaA 2Q Ebitda Before Exceptional Items at EUR1.52B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Says It Faced Strong Currency Headwinds
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Adjusts 2025 View
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Raises 2025 Guidance for Organic Growth in Ebitda Before Exceptional Items
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA Narrows 2025 Organic Sales Growth Guidance
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA 2Q EBITDA EUR1.35B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA 2Q After-Tax Profit EUR655M
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA 2Q Sales EUR5.255B
DJ
Read
7 sie 2025, 05:00 UTC
Merck KGaA 2Q Ebitda Before Exceptional Items EUR1.46B
DJ
Read
7 sie 2025, 05:00 UTC
Germany's Merck KGaA Says 2Q Sales Grew 2% Organically
DJ
Read
6 sie 2025, 14:14 UTC
Merck KGaA's Sales, Adjusted Earnings Expected to Be Little Changed -- Market Talk
DJ
Read
15 maj 2025, 08:21 UTC
Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks
DJ
Read
15 maj 2025, 06:53 UTC
Merck KGaA's Guidance Cut Should Cause Share-Price Pressure -- Market Talk
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA: Guidance Cut Reflects Impact of Current Macro-Economic, Geopolitical Environment
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA 1Q EBITDA EUR1.48B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Read
15 maj 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Net Sales Between EUR20.9B and EUR22.4B
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 146 EUR 35.06%
High 182 EUR
Low 100 EUR
Based on 10 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.
By TipRanks
Buy
10 ratings
8
Buy
1
Hold
1
Sell
Based on 10 analysts giving stock ratings to Merck KGaA - Dist in the past 3 months.
By Trading Central
Short Term
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Neutral Evidence
The bullish and bearish events are balanced.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$